Here's What We Learned From Virginia's Election Results
A Reporter Asked This Question Regarding Iran...and It Set Trump Off
It's an Underreported Story, But Also a Glaring National Security Issue
Does the Right Still Believe in 'No More Souters'?
Faith Rebound: Signs of Spiritual Awakening Continue As Gen Z Turns to God,...
There Is a Reason Why There Are So Few Great Men Today
The New York Times Finds a Glamorous Backer of Theft and Murder
A 21st Century Declaration of American Ideals
All Redistricting Reformers Are Hypocrites
Exposed: A Suspected Sex Trafficking Operation Steps From NBC, Fox News in Midtown...
Trump Cuts FDA Red Tape on Ibogaine: Veterans Finally Get a Real Shot...
Kansas Legislature Shows Rest of Nation How to Get Good Things Done
Chicago Public Schools and Mayor Brandon Johnson Declare ‘Day of Civic Action’ on...
Trump and Tennessee Republicans Are Delivering Affordable Energy
FBI, DEA Seize 120 Pounds of Meth, 25 Guns in Massive Mexican Mafia...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos